-
-
Small Molecule Drug Platform
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Flow-through cell
显示更多 -
-
Peptide Platform
显示更多 -
Research Team
显示更多
-
Service Platform
Related Services and Solutions
We look forward to working with you and providing you with excellent service.
DP Production Base — Siwei Pharma
Siwei Pharma supports end-to-end DP R&D and production from preclinical development, registration batch manufacturing, to commercial production.
Floor area:Approx. 120,000 m2
Quality management:We plan to build five solid dosage form workshops and two injection workshops that meet Chinese, US, and EU regulatory standards.
Dosage forms:We plan to produce a wide range of dosage forms, including solid and liquid dosage forms and powders for injection.
Production Equipment
Business Collaboration
Innovative Drug CDMO Services